1217191

Gregory D. Parkhurst, MD — FEI 3010342232

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 1, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
San Antonio, TX (United States)

Additional Details

Clinical Investigator (CI)